Edward Miller
CIK 1619252 · General Counsel · last filed 2025-02-24
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
1
Total Filings
40
Lifetime Open-Market Net
-$296.7K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Kalaris Therapeutics, Inc. (ALVR) Delisted | General Counsel | 21,575 | $9.81 | $211.7K | -$296.7K | 32 | 2025-02-24 |
Recent Filings · Page 4 of 4
40 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-08-06 | Kalaris Therapeutics, Inc. (ALVR) Delisted | Conv (C) | +32,759 | $0 | EDGAR |
| 2020-07-31 | Kalaris Therapeutics, Inc. (ALVR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-03-01 | — | Mixed | +3,810 | -$77.6K | |
| 2017-02-08 | — | Sell (S) | −1,045 | -$131.4K | |
| 2016-09-09 | — | Sell (S) | −367 | -$47.1K | |
| 2016-03-01 | — | Mixed | +2,671 | -$45.7K | |
| 2016-02-08 | — | Mixed | +7,751 | -$150.3K | |
| 2015-09-10 | — | Sell (S) | −366 | -$65.7K | |
| 2015-03-03 | — | Grant (A) | +3,830 | $0 | |
| 2014-09-12 | — | Grant (A) | +3,000 | $0 |
Showing 31–40 of 40
Prev
Page 4 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.